These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23046323)

  • 1. The pitfalls of femoropopliteal stenting trials.
    Mwipatayi BP; Leong BD; Hockley J; Vijayan V
    J Endovasc Ther; 2012 Oct; 19(5):596-8. PubMed ID: 23046323
    [No Abstract]   [Full Text] [Related]  

  • 2. Three-year outcomes of the RESILIENT trial: are they enough to support a primary stenting policy?
    Davies MG
    J Endovasc Ther; 2012 Feb; 19(1):10-1. PubMed ID: 22313194
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials.
    Acin F; de Haro J; Bleda S; Varela C; Esparza L
    J Endovasc Ther; 2012 Oct; 19(5):585-95. PubMed ID: 23046322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New stents for SFA.
    MINAR E; SCHILLINGER M
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):635-45. PubMed ID: 19741579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary nitinol stenting for femoropopliteal disease.
    Mewissen MW
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful complex bifurcation stenting of a native SFA after failed femoropopliteal bypass grafting.
    Kelley M; Mishkel G
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):602-9. PubMed ID: 17894306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
    J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Femoropopliteal subintimal angioplasty and nitinol stenting: a marriage of technique and technology...but will it last?
    Rocha-Singh K
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):544-6. PubMed ID: 15926181
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses.
    Cotroneo AR; Pascali D; Iezzi R
    J Endovasc Ther; 2008 Jun; 15(3):283-91. PubMed ID: 18540701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regarding "Stenting for femoropopliteal lesions".
    Schillinger M; Minar E
    J Vasc Surg; 2008 Jul; 48(1):252; author reply 252-3. PubMed ID: 18589243
    [No Abstract]   [Full Text] [Related]  

  • 12. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis.
    Mwipatayi BP; Hockings A; Hofmann M; Garbowski M; Sieunarine K
    J Vasc Surg; 2008 Feb; 47(2):461-9. PubMed ID: 17950563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited commentary.
    Rasmussen TE
    J Vasc Surg; 2009 Sep; 50(3):548. PubMed ID: 19700092
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: "Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses".
    Parmar V
    J Endovasc Ther; 2008 Oct; 15(5):628-9; author reply 629-30. PubMed ID: 18840055
    [No Abstract]   [Full Text] [Related]  

  • 15. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug coated ballons for femoro-popliteal interventions.
    Tamburrini L; Vosseler M; Espinola-Klein C
    Vasa; 2018 Jan; 47(1):68-69. PubMed ID: 29281955
    [No Abstract]   [Full Text] [Related]  

  • 17. The evidence for stenting in femoropopliteal occlusive disease.
    Minar E; Schillinger M
    Acta Chir Belg; 2008; 108(3):292-7. PubMed ID: 18710101
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries.
    Sabeti S; Mlekusch W; Amighi J; Minar E; Schillinger M
    J Endovasc Ther; 2005 Feb; 12(1):6-12. PubMed ID: 15683273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: nitinol stents for femoropopliteal disease: what is the view from the SUMMIT?
    Armstrong EJ
    J Endovasc Ther; 2013 Dec; 20(6):767-9. PubMed ID: 24325692
    [No Abstract]   [Full Text] [Related]  

  • 20. In-stent restenosis: while not exactly about smoking, it so often is about smoking.
    Butman S
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):609-10. PubMed ID: 21953756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.